Shares of Roche Holding Ltd. (VTX:ROG) have received an average recommendation of “Hold” from the twenty-one brokerages that are covering the firm, MarketBeat reports. Four analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and ten have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is CHF 253.74.
A number of brokerages recently issued reports on ROG. UBS Group set a CHF 237 price target on Roche and gave the stock a “neutral” rating in a research report on Tuesday, February 20th. Jefferies Group set a CHF 290 price target on Roche and gave the stock a “buy” rating in a research report on Monday. Kepler Capital Markets set a CHF 236 price target on Roche and gave the stock a “neutral” rating in a research report on Tuesday, February 20th. DZ Bank set a CHF 270 price target on Roche and gave the stock a “buy” rating in a research report on Friday, February 2nd. Finally, JPMorgan Chase & Co. reissued a “buy” rating on shares of Roche in a research report on Friday, February 2nd.
Shares of Roche (VTX ROG) traded up CHF 1.25 during trading hours on Wednesday, reaching CHF 223.30. The company had a trading volume of 1,510,000 shares, compared to its average volume of 2,330,000. The firm has a market capitalization of $193,210.00 and a P/E ratio of 22.24. Roche has a 1-year low of CHF 214.30 and a 1-year high of CHF 273.
COPYRIGHT VIOLATION WARNING: This piece was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/3224269/roche-holding-ltd-rog-receives-average-rating-of-hold-from-analysts.html.
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.